DatasetName,PHKB_S(24) PHKB_S(677) PHKB_S(694) PHKB_S(823) PHKB_T(232) PHKB_T(724) PHKB_Y(213) PHKB_Y(29),PHKB_S(2) PHKB_S(231) PHKB_S(27) PHKB_S(693) PHKB_S(7) PHKB_S(700) PHKB_S(701) PHKB_S(704) PHKB_T(695) PHKB_T(702) PHKB_Y(22),PHKB_S(25) PHKB_S(3) PHKB_S(4)
RM2024_Intensity D4-1___3,,,
RB2022_4_PostEndurance,,0.5462896525625885,
FSO2013_Ratio M/L normalized Rep3,,,
SR2019_MCF7_Biol_repl_3,,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,,
SR2019_LM2_Biol_repl_1,,,
RCJD2014_15min_1,,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,,
CK2022_7 16-1,,,
NJH2025_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_C,,0.5480036820579793,
RKK2015_TNF-α/basal,,,
JJ2018_Ratio H/M normalized pP2,,,
NJH2025_Sub12_MICT_Pre,,,
NJH2025_Sub7_MICT_Post,,,
DL2023_control-3,,0.5487528462135103,
ZX2022_Control Replicate 2,,0.5560842644688052,
HS2024_6_B_T3,,,
JW2015_Intensity pre1,0.47400364790890714,0.5609503334303104,
IMM2018_normalised rep. int. Empty-3,,,
AMK2021_30R_p5,,,
FSO2013_Ratio M/L normalized Rep1,,,
SR2019_MDAMB231_Biol_repl_4,,,
GF2025_P2_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,,
NJH2025_Sub13_HIIT_Mid,,,
CP2009_Ratio M/L,,,
NJH2025_Sub7_HIIT_Post,,,
KBE2022_Log2_Ex_44_T,,0.5591643381311532,
DB2022_Intensity L2,,0.5389969926989664,
TM2022_mock.4h.C,,,
AST2020_anti-CD3.2,,,
CW2012_10 µM Erl/control Experiment 1 Replicate B,,,
HS2024_7_B_N1,,,
FSO2013_Ratio M/L normalized Rep1___1,,,
SAS2015_AZD/DMSO_Exp3,,,
RM2024_Intensity D0-2___3,,,
RM2024_Intensity D6-1,,,
RB2022_8_RecoverySprint,0.45360204681051547,0.5487347838056646,
RB2022_5_PreEndurance,,0.5431332801631332,0.6725494568456686
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,,
EP2017_Untreated R#4 normalized log2 ratio,,0.5410106179794509,
WZ2023_Pu_010_30min,,0.5629913907790836,
AS2011_Ratio H/L Proteins RNAi_2,,,
RB2022_4_PreStrength,0.45417390450650263,0.5630475480928171,
NJH2024_Sub4_MICT_Post,,,
AH2018_LFQ_M_1_X,,0.5473416769332513,
RB2022_8_RecoveryEndurance,,,
KBE2022_Log2_Ex_14_U,,0.5530140729084617,
FSO2013_Ratio M/L normalized Rep3___3,,,
AH2018_TMTMS3_1_C,,0.553277860266446,
JJ2018_Ratio H/L normalized___1,,,
ZQ2022_C2,,0.5520185959100261,
RB2022_5_PreSprint,0.4444648341664292,0.5541233691086357,0.6731891743536947
PG2020_Intensity 8h_C,,,
AH2018_SILAC_MR_2_N,,,
MV2014_Ratio M/L normalized A1___2 (2 min),,,
TM2022_S2.8h.B,,,
MV2014_Ratio M/H normalized B3___1 (30 min),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,,
RM2024_Intensity D6-1___2,,,
NJH2025_Sub7_MICT_Mid,,,
LY2019_P1+,,0.5452103492279218,
AS2011_Ratio H/L Proteins Inhi_2,,,
BS2014_Log2(Ratio H/L normalized),,,
UK2020_HCM_2,,0.5485091237016204,
FSO2013_Ratio H/L normalized Rep2___2,,,
EP2017_Pervanadate R#3 normalized log2 ratio,,0.5706152162725847,
RM2024_Intensity D4-3___3,,,
RB2022_5_PreStrength,0.45652953057549206,0.5526989883343941,0.669591677422281
NJH2024_Sub4_MICT_Mid,,,
TM2022_S2.4h.A,,,
RB2022_5_PostStrength,,,
GF2025_P6_Sph,,,
RB2022_2_PreSprint,0.4544915585930452,0.5636638984532549,0.6320374199324797
ZX2022_CB treated Replicate 3,,0.5563578267953618,
RM2024_Intensity D6-2___3,,,
WZ2023_Pe_025_10min,,0.5616524764337429,
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,,
AST2020_anti-CD3+PDL2.1,,,
KBE2022_Log2_Ex_34_U,,0.5599379807923306,
WZ2023_Pu_005_10min,,0.5653518040513682,
AS2011_Ratio H/L RNAi_2_1,,,
NJH2024_Sub9_HIIT_Mid,,,
CK2022_9 40-1,,,
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,,
LG2023_GSK3α-1_intensity,,,
WZ2023_Pu_025_30min,,0.56476608159646,
AH2018_SILAC_MR_2_X,,,
HS2024_4_PD_T2,,,
NJH2024_Sub4_HIIT_Pre,,,
RB2022_2_RecoverySprint,0.46719942633646794,0.5342734849642442,0.7073322031098274
AS2011_Ratio H/L Protein RNAi_1,,,
RM2024_Intensity D2-1___2,,,
CR2017_Ratio Replicate 1.4,,0.5182421363741234,
FR2021_Norm.Intensity.B,,,
RM2024_Intensity D6-2___1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,,
RB2022_5_PostSprint,0.46526923311543483,0.5676153765388413,0.6879502385352326
EJN2021_3_Rest_Basal,0.45513148098089656,0.5624939210465585,
CR2017_Ratio Replicate 1.3,,0.5331472297655896,
AS2011_Ratio H/L Normalized by Protein RNAi_2,,,
KTGR2014_Ratio-Rapa 7 mins,,,
AMK2021_120R_p1,,,
AH2018_SILAC_3_X,,0.5418726444623134,
JJ2018_Ratio M/L normalized pP3,,,
AH2018_SILAC_M_2_N,,0.5296223661816134,
HS2024_7_PD_T2,,,
FSO2013_Ratio H/L normalized Rep1___1,,,
AH2018_LFQ_1_C,,,
AS2011_Ratio H/L Normalized Inhi_1_3,,,
KBE2022_Log2_Ex_28_T,,0.5552310135923917,
HS2024_3_B_N1,,,
RM2024_Intensity D4-2___3,,,
WZ2023_Pe_025_30min,,0.5627340542223718,
CK2022_11 40-1,,,
CW2012_10 µM Erl/control Experiment 3 Replicate B,,,
AH2018_SILAC_2_X,,0.5167774780894338,
MV2014_Ratio H/M normalized A2___2 (2 min),,,
AS2011_Ratio H/L RNAi_1_2,,,
KS2014_Intensity E15_1,,0.5683400363007265,
FSO2013_Ratio H/L normalized Rep2,,,
WZ2023_Pu_005_20min,,0.5648445340255912,
NJH2024_Sub10_MICT_Post,,,
RM2024_Intensity D2-3___1,,,
CR2017_Ratio Replicate 1.5,,0.5147311636194843,
CW2012_10 µM Gef/control Experiment 2 Replicate B,,,
HS2024_7_B_T3,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,,
AS2011_Ratio H/L RNAi_1,,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,,
AH2018_LFQ_M_1_C,,0.547484975658989,
NJH2025_Sub7_MICT_Pre,,,
SR2019_SKBR3_Biol_repl_2,,0.5394129112282164,
HS2024_9_B_T2,,,
KTGR2014_Ratio-AA 7 mins,,,
MV2014_Ratio L/H normalized B3___3 (5 min),,,
HS2024_3_PD_T1,,,
FSO2013_Ratio M/L normalized Rep3___2,,,
SR2019_BT549_Biol_repl_3,,,
RCJD2014_20min_mean,,,
FR2021_Norm.Intensity.H,,,
RB2022_2_PreStrength,0.4597603616799536,,0.603751609567764
DB2022_LFQ intensity L1.2,,0.5418007537044303,
HS2024_4_B_N1,,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,,
CK2022_1 16-1,,,
CK2022_1 200-1,,,
PG2020_Intensity Mock_10h_D,,,
SR2019_MCF10A_Biol_repl_2,,0.5348023991142968,
JJ2018_Ratio M/L normalized pP2___2,,,
HS2024_6_PD_T1,,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,,
RB2022_6_RecoveryEndurance,0.46356297400423296,0.561149935012091,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,,
EP2017_Mitotic R#2 normalized log2 ratio,,0.5417015304473013,
RCJD2014_5min_1,,,
RM2024_Intensity D4-1___1,,,
DL2023_24h-1,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,,
TM2022_S2.4h.C,,,
SAS2015_PLX/AZD_Exp2,,,
CR2017_Ratio Replicate 3.3,,0.5470079251680469,
PG2020_Intensity 2h_C,,,
VOI2024_Veh2 di,,,
ZX2022_CB treated Replicate 2,,0.5582968692573194,
KBE2022_Log2_Ex_8_T,,0.5564550836587464,
NJH2025_Sub10_MICT_Post,,,
HS2024_6_I_T3,,,
RN2012_L11,,0.5562027464252699,
AS2011_Ratio H/L Normalized Inhi_2_2,,,
IMM2018_normalised rep. int. Empty-1,,,
HS2024_5_PD_T1,,,
AH2018_LFQ_M_2_C,,0.5540984599831863,
CK2022_3 40-1,,,
RBK2021_1260T Early,,,
NJH2024_Sub4_HIIT_Post,,,
HS2024_4_I_T1,,,
YA2020_Reporter_intensity_Cancer_No.5,,0.5622478111086595,
HH2022_Reporter intensity 8,,,
ZQ2022_N2,,0.5487685073595482,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,,
FSO2013_Ratio H/L normalized Rep3___3,,,
AH2018_TMTMS3_2_N,,0.5587889784293077,
EJN2021_5_Rest_Basal,0.4619843211307029,0.5630389588368108,
NJH2025_Sub2_HIIT_Post,,,
NJH2025_Sub1_MICT_Post,,,
HS2024_9_B_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,,
JAW2011_Ratio H/L LS2_1,,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,,
NJH2024_Sub6_HIIT_Pre,,,
AH2018_SILAC_3_N,,0.5431110436833246,
YA2020_Reporter_intensity_Normal_No.1,,0.5589862849618177,
HS2024_3_B_T1,,,
JJ2018_Ratio H/L normalized___2,,,
RM2024_Intensity D0-2,,,
MV2014_Ratio M/L normalized B1___2 (5 min),,,
RB2022_7_PostStrength,0.45615509974760615,0.5577701268528265,0.6518000896135807
RB2022_1_PostEndurance,,0.5489994678555006,0.675755375413933
CR2017_Ratio Replicate 3,,0.5514535724212712,
SR2019_Hs578T_Biol_repl_3,,,
MV2014_Ratio L/H normalized B3___1 (5 min),,,
RBK2021_1244T Early,,,
RB2022_3_PostSprint,,0.5338832449958804,0.6009115202000831
NJH2024_Sub13_MICT_Mid,,,
KTGR2014_Ratio-AA 2 mins,,,
GF2025_P7_Sph,,,
HS2024_8_I_T3,,,
CF2017_EOC 3,,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,0.5670256133181462,
HS2024_6_PD_T3,,,
DL2023_12h-2,,0.5473632440706441,
RM2024_Intensity D6-3___1,,,
FS2019_Ctr1,,,
WZ2023_Pu_010_20min,,0.5632091334448354,
AS2011_Ratio H/L_3,,,
CK2022_1 40-1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D1,,,
CK2022_8 16-1,,,
KS2014_Intensity N3,,0.5591324693107869,
RB2022_4_RecoveryEndurance,0.4513213560247971,0.5568895141791821,
RB2022_5_RecoveryEndurance,0.4658868473089803,0.5516023575011135,0.5701348216615542
JAW2011_Ratio H/L LS1a_2,,,
NJH2024_Sub12_HIIT_Mid,,,
AH2018_LFQ_IT_1_N,,0.5473524479501097,
FSO2013_Ratio H/M normalized Rep2,,,
RAM2015_Log2 A,,,
HS2024_8_PD_T1,,,
JJ2018_Ratio H/L normalized pP2,,,
CF2017_OSE 27,,,
KS2014_Intensity E15_2,,0.5685360950038088,
BS2014_Log2(Ratio H/L protein),,,
PG2020_Intensity 8h_A,,,
HS2024_7_I_T1,,,
VOI2024_Veh3 di,,,
RKK2015_TNF-α+SC-514/basal,,,
SR2019_JIMT1_Biol_repl_1,,,
HW2015_Ratio H/L normalized Exp2,,,
HS2024_3_I_N1,,,
AH2018_SILAC_M_3_X,,0.5424988311821828,
NJH2024_Sub9_HIIT_Post,,,
AS2011_Ratio H/L RNAi_1_3,,,
GRW2016_Ratio H/L normalized SILAC 1___2,,,
NJH2025_Sub1_HIIT_Pre,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,,
NJH2024_Sub4_HIIT_Mid,,,
VOI2024_0.1uM 2 h_1 di,,,
KBE2022_Log2_Ex_6_T,,0.5551327030002856,
RM2024_Intensity D4-3___1,,,
AH2018_LFQ_4_X,,0.5400954222190145,
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
RB2022_8_PostEndurance,0.4590973515862956,0.5588761180355178,
NJH2025_Sub4_MICT_Mid,,,
YP2020_Intensity C30_R1_mult_log2,,,
AST2020_anti-CD3.1,,,
NJH2025_Sub4_HIIT_Post,,,
EP2017_Untreated R#4 log2 ratio,,0.5409220642973427,
HS2024_6_B_N1,,,
KBE2022_Log2_Ex_27_T,,0.5524532164799016,
CW2012_10 µM Gef/control Experiment 1 Replicate A,,,
VOI2024_0.1uM 24 h_1 mono,,,
AMK2021_120R_p5,,,
AS2011_Ratio H/L Proteins,,,
NJH2024_Sub7_HIIT_Post,,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,0.5679025456683623,0.6435959957322381
AS2011_Ratio H/L RNAi_2_2,,,
RB2022_7_RecoveryStrength,0.46151531524288214,0.5643099240517294,0.6647922364467292
AH2018_SILAC_IT_3_X,,0.5301028057491828,
JAW2011_Ratio H/L,,,
PG2020_Intensity 10h_C,,,
FSO2013_Ratio M/L normalized Rep2,,,
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,,
HH2022_Reporter intensity 5,,,
SR2019_HCC1954_Biol_repl_2,,0.5493626553982701,
CK2022_14 40-1,,,
RB2022_6_PreSprint,,0.5570059211107071,
NJH2025_Sub12_MICT_Mid,,,
PG2020_Intensity 4h_D,,,
NJH2025_Sub2_MICT_Post,,,
AH2018_LFQ_4_C,,,
DL2023_control-1,,0.548861707248211,
AR2021_ALG 10 μM,,,
JAW2011_Ratio H/L LS2_2,,,
AH2018_SILAC_IT_3_N,,0.5516036448000093,
EJN2021_4_Rest_Ins,0.46806093955935424,0.5405139775948736,
RN2012_H05,,,
NJH2024_Sub7_HIIT_Mid,,,
GF2025_P2_Adh,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,,
RB2022_8_PostSprint,0.46799884739102887,0.5697979878489293,
EJN2021_1_Rest_Ins,0.47489231626034645,0.5686276175355869,
HH2022_Reporter intensity 3,0.4582190703097245,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,,
AH2018_SILAC_IT_1_C,,0.5525552954164574,
JW2021_After_3,,0.556606833901001,
GF2025_P8_Sph,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,,
JJ2018_Ratio M/L normalized pP2___1,,,
AH2018_SILAC_2_N,,0.5278669723309997,
CK2022_11 200-1,,,
CK2022_12 200-1,,,
AS2011_Ratio H/L Normalized by Protein RNAi_1,,,
RM2024_Intensity D2-1___3,,,
NJH2024_Sub1_MICT_Pre,,,
HH2022_Reporter intensity 9,,,
WZ2023_Su_010_20min,,0.5649813102062489,
AH2018_TMTMS2_2_N,,0.5546376661061078,
NJH2024_Sub13_MICT_Pre,,,
KBE2022_Log2_Ex_41_U,,0.5555582282593998,
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,0.5372001436299096,0.6062734217577024
AH2018_TMTMS3_Pool,,0.5584901410776161,
KS2014_Intensity N4,,0.563350824463787,
NJH2024_Sub1_HIIT_Post,,,
MM2018_Ratio H/L replicate2,,,
RM2024_Intensity D4-2___2,,,
NJH2024_Sub13_HIIT_Pre,,,
CF2017_OSE 26,,,
CK2022_14 200-1,,,
SR2019_Hs578T_Biol_repl_1,,,
RB2022_7_PostSprint,0.43287260512098336,0.5615676855279538,0.6688816282266901
TM2022_mock.4h.A,,,
NJH2025_Sub12_HIIT_Pre,,,
AH2018_TMTMS3_1_N,,0.5593530627130918,
AST2020_anti-CD3+PDL2.2,,,
PG2020_Intensity Mock_10h_A,,,
JW2021_After_2,,0.5595233646932593,
NJH2024_Sub2_MICT_Post,,,
EJN2021_2_Rest_Ins,0.4686285042524089,0.5337703887557487,
SR2019_LM2_Biol_repl_4,,,
CP2009_Ratio H/M,,,
JAW2011_Ratio H/L HS,,,
CK2022_13 16-1,,,
GF2025_P1_Adh,,,
GF2025_P1_Sph,,,
EJN2021_5_Ex_Basal,0.45773442706002726,0.5638879559379276,
HS2024_7_I_T3,,,
JJ2018_Ratio H/L normalized pP2___2,,,
WZ2023_Pe_010_10min,,0.5627826602659464,
CF2017_EOC 1,,,
CK2022_3 200-1,,,
AH2018_LFQ_IT_3_C,,0.5121417987828999,
SR2019_Hs578T_Biol_repl_2,,0.5506939138929439,
NJH2024_Sub12_HIIT_Post,,,
JJ2018_Ratio H/L normalized pP1___2,,,
MV2014_Ratio H/L normalized A1___2 (10 min),,,
NJH2024_Sub10_MICT_Mid,,,
NJH2024_Sub13_MICT_Post,,,
BS2014_Log2(Ratio H/L normalized Rep_1),,,
RB2022_3_RecoverySprint,0.4857871059595204,0.5691999251854258,0.6732400626819274
NJH2025_Sub1_HIIT_Mid,,,
RCJD2014_20min_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,,
HS2024_6_PD_T2,,,
HS2024_5_B_T1,,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,,
DL2023_12h-3,,,
SR2019_MDAMB231_Biol_repl_2,,,
HS2024_3_B_T2,,,
RB2022_6_PreStrength,0.4709304153035731,0.5644195791020499,
CK2022_2 40-1,,,
RB2022_1_PostSprint,0.4655895974015414,0.5605973352510525,0.6469670058047955
CK2022_4 200-1,,,
JW2021_Before_2,,0.5501844725537354,
TM2022_S2.12h.A,,,
MV2014_Ratio L/M normalized B2___2 (30 min),,,
CK2022_5 16-1,,,
AR2021_ALG 1 μM,,,
HS2024_4_B_T1,,,
MV2014_Ratio M/H normalized A3___1 (10 min),,,
SR2019_BT549_Biol_repl_4,,,
EJN2021_1_Rest_Basal,0.45610525205164476,0.5706319722386564,
NJH2025_Sub8_MICT_Post,,,
RCJD2014_5min_3,,,
CR2017_Ratio Replicate 3.2,,0.5628799572031467,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,,
GF2025_P7_Adh,,,
CK2022_9 16-1,,,
NJH2024_Sub6_HIIT_Post,,,
AMK2021_30R_p3,,,
AS2011_Ratio H/L Normalized RNAi_2,,,
RM2024_Intensity D0-2___2,,,
KS2014_Intensity pY_N4,,,
CK2022_13 200-1,,,
AS2011_Ratio H/L Normalized_2,,,
PG2020_Intensity 6h_D,,,
CK2022_16 16-1,,,
FS2019_db/db3,,,
CK2022_15 40-1,,,
NJH2024_Sub9_MICT_Pre,,,
BS2014_Log2(Ratio H/L unmodified peptide),,,
WZ2023_Su_005_10min,,0.5647950446771699,
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,,
KBE2022_Log2_Ex_41_T,,0.5572631143206846,
AMK2021_Ctrl_p1,,,
AH2018_LFQ_IT_3_X,,0.5166248252222765,
HS2024_5_PD_T3,,,
AH2018_TMTMS3_3_X,,0.5579157471157076,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,,
KBE2022_Log2_Ex_40_U,,0.555987564451061,
AH2018_LFQ_M_1_N,,0.5465168352724555,
KBE2022_Log2_Ex_27_U,,0.5534671152814551,
HW2015_Ratio M/L normalized Exp3,,,
RKK2015_TNF-α/IKKb(K44M),,,
AH2018_SILAC_M_1_N,,0.5477051628364564,
HW2015_Ratio M/L normalized Exp1,,,
RB2022_5_RecoveryStrength,0.465080990725148,0.5635521271282126,0.6573879704047848
YP2020_Intensity P10_R1_mult_log2,,,
RB2022_7_PreStrength,0.46801173572336435,0.5414669678509165,
YA2020_Reporter_intensity_Normal_No.4,,0.5612408727678673,
NJH2025_Sub13_HIIT_Pre,,,
PG2020_Intensity CT_D,,,
NJH2025_Sub9_MICT_Post,,,
VOI2024_Veh1 mono,,,
CK2022_12 16-1,,,
RN2012_L13,,,
LG2023_Control-1_intensity,,,
RM2024_Intensity D6-3___2,,,
KBE2022_Log2_Ex_8_U,,0.5611253337873592,
SR2019_SKBR3_Biol_repl_3,,0.5598887263555954,
NJH2024_Sub1_MICT_Post,,,
HS2024_3_I_T2,,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,,
RM2024_Intensity D0-3___3,,,
HS2024_6_I_T2,,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,,
AS2011_Ratio H/L Protein Inhi_1,,,
FSO2013_Ratio H/M normalized Rep2___1,,,
GRW2016_Ratio M/L normalized SILAC 5a___2,,,
CK2022_10 40-1,,,
NJH2024_Sub12_HIIT_Pre,,,
NJH2024_Sub8_MICT_Pre,,,
RM2024_Intensity D0-1___1,,,
LY2019_P3+,,0.5557024485967609,
HH2022_Reporter intensity 6,0.4712237731323493,,
RB2022_2_RecoveryStrength,0.44500936152901666,,0.6300455423660718
KTGR2014_Ratio-AA 15 mins,,,
AS2011_Ratio H/L Normalized RNAi_2_2,,,
KS2014_Intensity pY_N3,,,
MV2014_Ratio H/L normalized B1___2 (30 min),,,
LY2019_P5-,,0.5523024384769427,
HW2015_Ratio M/L normalized Exp2,,,
SR2019_HCC1419_Biol_repl_1,,0.5644223863250563,
AH2018_TMTMS2_3_X,,0.555125911719969,
GF2025_P3_Adh,,,
SR2019_JIMT1_Biol_repl_2,,0.5382770429840146,
AH2018_TMTMS2_1_C,,0.55466107085436,
RM2024_Intensity D0-1___2,,,
LY2019_P4+,,0.5572373409401051,
KBE2022_Log2_Ex_19_U,,0.5529124882413803,
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,,
RB2022_4_PostStrength,0.45982325571923893,0.5665978821416707,
LG2023_GSK3α-3_intensity,,,
YA2020_Reporter_intensity_Cancer_No.1,,0.5640798659045364,
AST2020_Control,,,
JAW2011_Ratio H/L LS1a,,,
RCJD2014_5min_mean,,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,,0.6746291119945113
NJH2025_Sub1_MICT_Mid,,,
TM2022_S2.12h.C,,,
NJH2025_Sub9_MICT_Mid,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,,
AS2011_Ratio H/L Normalized Inhi_1_2,,,
FSO2013_Ratio M/L normalized Rep2___1,,,
LG2023_Control-2_intensity,,,
NJH2024_Sub8_HIIT_Pre,,,
KS2014_Intensity pY_N2,0.4146921033402126,,
RB2022_5_RecoverySprint,,0.5421427567907716,0.5998800511410203
RB2022_7_RecoverySprint,0.45768559524944363,0.5357036289444808,0.6259954322987654
YA2020_Reporter_intensity_Normal_No.3,,0.5555943288168222,
HS2024_8_B_T2,,,
AH2018_LFQ_1_X,,0.5527979769886384,
RM2024_Intensity D6-1___1,,,
RCJD2014_10min_2,,,
FR2021_Norm.Intensity.M,,,
RM2024_Intensity D0-3___1,,,
KS2014_Intensity N2,,0.5637774147522641,
HH2022_Reporter intensity 1,0.45704379903378783,,
HH2022_Reporter intensity 2,0.4579005869727227,,
RM2024_Intensity D6-2___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,,
RM2024_Intensity D2-3___2,,,
YA2020_Reporter_intensity_Normal_No.5,,0.5607717017580304,
SR2019_MCF7_Biol_repl_1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,,
HS2024_8_B_T1,,,
NJH2025_Sub6_HIIT_Pre,,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,,
EP2017_Untreated R#2 log2 ratio,,0.5549817910961625,
SR2019_LM2_Biol_repl_3,,,
RB2022_4_RecoveryStrength,0.43590228798937697,,
CR2017_Ratio Replicate 2,,0.5579117462307619,
CW2012_10 µM Erl/control Experiment 2 Replicate A,,,
FSO2013_Ratio H/M normalized Rep3,,,
AR2021_KD 72h,,,
MV2014_Ratio H/M normalized B2___3 (5 min),,,
KBE2022_Log2_Ex_18_U,,0.5627627675856834,
AS2011_Ratio H/L Inhi_1_1,,,
NJH2024_Sub8_MICT_Post,,,
AH2018_TMTMS3_3_C,,0.5573388305919807,
KBE2022_Log2_Ex_9_U,,0.5521020554653245,
AH2018_SILAC_M_3_N,,0.5436198894474192,
KBE2022_Log2_Ex_13_T,,0.5565159552301912,
RM2024_Intensity D0-3,,,
SR2019_SKBR3_Biol_repl_1,,0.5499946078077952,
PG2020_Intensity Mock_10h_C,,,
CF2017_OSE 29,,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,,
NJH2025_Sub1_HIIT_Post,,,
DL2023_24h-2,,0.552812137083114,
HS2024_7_B_N2,,,
PG2020_Intensity 10h_A,,,
RN2012_L12,,0.5587028247673159,
MV2014_Ratio M/L normalized B1___3 (5 min),,,
NJH2024_Sub8_MICT_Mid,,,
AH2018_LFQ_IT_4_C,,0.5419278007223233,
SAS2015_PLX/AZD_Exp1,,,
FR2021_Norm.Intensity.A,,,
FSO2013_Ratio H/M normalized Rep1___1,,,
JW2015_Intensity cap2,0.4547106984328973,0.5626833030676014,
BS2014_Log2(Ratio H/L normalized Rep_2),,,
NJH2024_Sub6_MICT_Post,,,
CK2022_8 40-1,,,
RB2022_7_RecoveryEndurance,,0.5541745070688221,0.6518053870690598
NJH2025_Sub12_HIIT_Post,,,
EJN2021_4_Ex_Basal,0.4687003936500484,0.5741275351879824,
TM2022_S2.12h.B,,,
RN2012_L15,,0.5444604218248393,
KS2014_Intensity pY_PV3,0.4782717238081816,,
TM2022_S2.4h.B,,,
PG2020_Intensity 4h_A,,,
FSO2013_Ratio H/M normalized Rep2___2,,,
TM2022_mock.4h.B,,,
KBE2022_Log2_Ex_24_U,,0.5556360563490332,
NJH2025_Sub13_MICT_Mid,,,
KS2014_Intensity C3,,0.5670167369035524,
RB2022_1_PreSprint,0.45456913640012625,0.55913968247352,0.6130364967579593
HS2024_4_I_N1,,,
CK2022_7 200-1,,,
CK2022_5 200-1,,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,,
FSO2013_Ratio H/L normalized Rep2___1,,,
NJH2024_Sub10_HIIT_Mid,,,
RB2022_2_PostEndurance,0.4635005390521854,0.5697081608553987,0.6937743156943519
AH2018_LFQ_2_C,,0.5518239792251161,
AH2018_SILAC_MR_1_X,,,
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,,
IMM2018_normalised rep. int. Empty-2,,,
RM2024_Intensity D4-1,,,
KBE2022_Log2_Ex_25_U,,0.5536208985615784,
AH2018_SILAC_3_C,,0.5419116006557156,
EJN2021_5_Rest_Ins,0.46119480877500063,0.5311876839595263,
VOI2024_0.1uM 24 h_3 di,,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,,
DB2022_LFQ intensity L2.1,,,
FSO2013_Ratio H/M normalized Rep1,,,
CK2022_4 16-1,,,
AS2011_Ratio H/L,,,
SR2019_MCF7_Biol_repl_4,,,
EJN2021_2_Ex_Ins,0.46489344276538697,0.5742760272985167,
AS2011_Ratio H/L Inhi_2_3,,,
JAW2011_Ratio H/L LS1a_1,,,
AH2018_LFQ_1_N,,0.5419519564309856,
SAS2015_PLX/DMSO_Exp1,,,
SFR2015_HL_log2_ratio_avg_c,,,
JJ2018_Ratio M/L normalized pP2,,,
NJH2024_Sub7_MICT_Mid,,,
PG2020_Intensity 6h_B,,,
FSO2013_Ratio H/L normalized Rep3,,,
GRW2016_Ratio H/L normalized SILAC 2___2,,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,,
JJ2018_Ratio M/L normalized,,,
KTGR2014_Ratio-AA 30 mins,,,
JW2021_After_1,,0.5622264924902965,
NJH2025_Sub2_MICT_Mid,,,
HS2024_6_B_N2,,,
KBE2022_Log2_Ex_9_T,,0.5546575148579933,
AH2018_SILAC_IT_2_N,,0.5515532978413805,
AH2018_SILAC_IT_1_X,,0.5131624143438726,
HW2015_Ratio H/L normalized Exp3,,,
HS2024_7_PD_T1,,,
UK2020_UA_2,0.4594144833884243,0.549774113877367,
RM2024_Intensity D2-1___1,,,
GF2025_P10_Sph,,,
WZ2023_Pe_025_20min,,0.5610738439410766,
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,,
AH2018_LFQ_2_N,,0.545044398959956,
HS2024_4_I_N2,,,
AH2018_TMTMS2_3_N,,0.5546711385729401,
RN2012_H06,,0.5637950107840287,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,,
HS2024_4_PD_T3,,,
WZ2023_Su_005_30min,,0.5644402564206813,
SR2019_HCC1419_Biol_repl_4,,0.5509337483872958,
JJ2018_Ratio H/M normalized___2,,,
SR2019_JIMT1_Biol_repl_3,,0.5546821270637099,
AS2011_Ratio H/L Protein,,,
UK2020_HCM_3,0.4622231592999196,0.5503439065513317,
NJH2024_Sub10_HIIT_Post,,,
CR2017_Ratio Replicate 3.1,,0.550897641749794,
WZ2023_Su_025_10min,,0.5667761250974913,
AH2018_LFQ_IT_4_X,,0.5418689498637147,
CP2009_Ratio H/L,,,
VOI2024_0.1uM 24 h_3 mono,,,
RB2022_4_RecoverySprint,0.48066573075157265,,
RM2024_Intensity D6-3,,,
WZ2023_Su_005_20min,,0.5659112917380992,
CW2012_10 µM Gef/control Experiment 1 Replicate B,,,
SFR2015_HL_log2_ratio_avg_a,,,
CW2012_10 µM Erl/control Experiment 3 Replicate A,,,
RB2022_1_PreEndurance,0.4428505725539838,0.5336913737111382,0.620154550302734
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,,
LG2023_GSK3α-2_intensity,,,
EP2017_Pervanadate R#1 log2 ratio,,0.5682146304938724,
NJH2025_Sub6_HIIT_Post,,,
RB2022_6_RecoverySprint,0.4655834815386977,0.5381209279148321,
KS2014_Intensity,0.4550652326810316,0.5724730213995378,
MV2014_Ratio H/M normalized A2___1 (2 min),,,
PG2020_Intensity 8h_D,,,
LY2019_P7+,,0.5511792251598835,
EP2017_Untreated R#1 normalized log2 ratio,,0.5438446720408213,
RN2012_L10,,,
PG2020_Intensity 4h_C,,,
EP2017_Mitotic R#3 normalized log2 ratio,,0.5344370754702689,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,,
DB2022_LFQ intensity L1,,0.5297664423945345,
KBE2022_Log2_Ex_24_T,,0.5564099522391612,
RB2022_8_PostStrength,,0.5537644864460501,
AH2018_SILAC_IT_2_X,,0.5186341852483779,
HS2024_4_B_T3,,,
NJH2024_Sub2_HIIT_Post,,,
HS2024_8_B_N2,,,
NJH2025_Sub8_HIIT_Pre,,,
JJ2018_Ratio H/L normalized pP2___1,,,
HS2024_8_I_T2,,,
KBE2022_Log2_Ex_6_U,,0.5572168128781414,
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,0.5716453608492112,
CR2017_Ratio Replicate 1.1,,0.5381565339293165,
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,,
MV2014_Ratio M/H normalized B3___2 (30 min),,,
CK2022_16 200-1,,,
VOI2024_0.1uM 2 h_3 di,,,
EP2017_Mitotic R#1 normalized log2 ratio,,0.5438264120376769,
GF2025_P9_Sph,,,
CK2022_6 200-1,,,
NJH2024_Sub7_MICT_Post,,,
AH2018_TMTMS3_2_X,,0.5551781735298372,
NJH2024_Sub8_HIIT_Post,,,
DB2022_LFQ intensity R1,,,
JW2015_Intensity cap3,0.4725478145912918,0.5445210925285991,
SR2019_HCC1954_Biol_repl_1,,0.5402126511138965,
HS2024_4_I_T2,,,
NJH2024_Sub2_MICT_Mid,,,
VOI2024_0.1uM 2 h_2 mono,,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,,
HS2024_4_PD_T1,,,
SAS2015_AZD/DMSO_Exp1,,,
NJH2024_Sub1_MICT_Mid,,,
IMM2018_normalised rep. int. CDK5L-3,,,
HS2024_3_B_T3,,,
MV2014_Ratio L/H normalized A3___2 (2 min),,,
NJH2025_Sub13_MICT_Pre,,,
SR2019_MDAMB231_Biol_repl_3,,,
GRW2016_Ratio H/L normalized SILAC 4___1,,,
MM2018_Ratio H/L replicate1,,,
PG2020_Intensity 2h_D,,,
EP2017_Untreated R#3 normalized log2 ratio,,0.5587256494094607,
MV2014_Ratio M/H normalized A3___3 (10 min),,,
NJH2024_Sub7_HIIT_Pre,,,
JAW2011_Ratio H/L LS2,,,
CK2022_8 200-1,,,
KS2014_Intensity pY_C4,,,
CR2017_Ratio Replicate 3.5,,0.5398002923523184,
RB2022_7_PostEndurance,0.4541973019370126,0.5685093420527303,0.6960875891737385
NJH2025_Sub4_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,,
TM2022_mock.12h.A,,,
JJ2018_Ratio H/L normalized pP1,,,
EP2017_Pervanadate R#2 normalized log2 ratio,,0.5708929898447113,
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,,
KS2014_Intensity pY_E5_4,,,
RM2024_Intensity D4-3___2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,,
AH2018_SILAC_2_C,,0.5121656927129908,
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
HS2024_7_I_N1,,,
KBE2022_Log2_Ex_29_T,,0.5550942545383013,
HS2024_7_I_T2,,,
AS2011_Ratio H/L Normalized RNAi_2_3,,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,,
HS2024_6_B_T2,,,
AMK2021_45I_p5,,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,,
SAS2015_PLX/DMSO_Exp2,,,
EJN2021_1_Ex_Basal,0.45253402633224177,0.571710231237666,
FR2021_Intensity.M,,,
RB2022_2_PostSprint,0.4607929905303517,0.5668462459614717,0.6734021129148063
AH2018_SILAC_MR_3_N,,,
MV2014_Ratio H/L normalized B1___3 (30 min),,,
CF2017_FTE 13,,,
PG2020_Intensity CT_C,,,
ZCP2016_Ratio H/L Rep 1,,,
FS2019_db/db2,,,
KS2014_Intensity pY_PV4,0.47475222187732713,,
KBE2022_Log2_Ex_39_U,,0.5522509063070408,
EP2017_Untreated R#3 log2 ratio,,0.5586675779249156,
RB2022_2_PostStrength,0.4633843256928903,0.5686483717979801,0.662894441420785
AS2011_Ratio H/L Normalized_1,,,
MV2014_Ratio M/H normalized A3___2 (10 min),,,
CR2017_Ratio Replicate 3.4,,0.5583995452534566,
HS2024_8_PD_T2,,,
FS2019_Ctr2,,,
RB2022_6_PreEndurance,0.47156466155934496,0.5431650636073004,
FR2021_Norm.Intensity.G,,,
NJH2025_Sub9_HIIT_Post,,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,,
RM2024_Intensity D4-3,,,
HS2024_8_B_N1,,,
NJH2025_Sub10_MICT_Mid,,,
KBE2022_Log2_Ex_15_U,,0.5622851752144659,
AS2011_Ratio H/L Normalized Inhi_2,,,
RKK2015_TNF-α/SC-514,,,
RB2022_3_PreSprint,0.46099744187508274,0.5635722648163466,0.6786149516510949
CR2017_Ratio Replicate 2.3,,0.5580358823821653,
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,,
GF2025_P4_Adh,,,
YA2020_Reporter_intensity_Normal_No.2,,0.5555796939324339,
YP2020_Intensity P30_R2_mult_log2,,,
NJH2025_Sub13_MICT_Post,,,
HS2024_4_B_N2,,,
HS2024_3_PD_T3,,,
AMK2021_120R_p3,,,
MV2014_Ratio L/H normalized A3___3 (2 min),,,
NJH2025_Sub10_HIIT_Pre,,,
FR2021_Intensity.G,,,
RAM2015_Log2 C,,,
AS2011_Ratio H/L Proteins Inhi_1,,,
FSO2013_Ratio H/M normalized Rep1___3,,,
AH2018_LFQ_M_2_N,,0.5501124048237834,
MV2014_Ratio M/L normalized A1___3 (2 min),,,
KBE2022_Log2_Ex_40_T,,0.5532014843854149,
CK2022_2 16-1,,,
RAM2015_Log2 B,,,
YP2020_Intensity C10_R1_mult_log2,,,
FSO2013_Ratio M/L normalized Rep1___2,,,
NJH2025_Sub8_MICT_Pre,,,
EJN2021_4_Rest_Basal,0.46243046302721397,0.5736585208225123,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,,
JJ2018_Ratio H/M normalized pP3___1,,,
VOI2024_Veh2 mono,,,
HS2024_6_B_T1,,,
UK2020_HCM_5,0.46021388880079117,0.5494515347093569,
NJH2025_Sub10_HIIT_Post,,,
VOI2024_0.1uM 2 h_3 mono,,,
JW2015_Intensity pre3,0.4652844733864974,0.5366197946674688,
AS2011_Ratio H/L Normalized Inhi_2_1,,,
DL2023_24h-3,,0.5527086940594365,
HS2024_7_PD_T3,,,
PG2020_Intensity Mock_10h_B,,,
WZ2023_Su_025_30min,,0.5663495576018288,
AH2018_LFQ_4_N,,0.5521065568312538,
CR2017_Ratio Replicate 1.2,,0.5368534935660886,
AS2011_Ratio H/L Normalized by Proteins,,,
RB2022_6_RecoveryStrength,0.4640919401730519,0.5466856859323088,
HS2024_8_I_N1,,,
AMK2021_Ctrl_p3,,,
AS2011_Ratio H/L Protein Inhi_2,,,
HH2022_Reporter intensity 7,,,
AH2018_SILAC_M_1_X,,0.5474805986550704,
RB2022_7_PreEndurance,0.46048074376358883,0.5492399989956135,0.6309134791816646
VOI2024_0.1uM 24 h_2 di,,,
DL2023_control-2,,0.5494292452256615,
LY2019_P6+,,0.5386040529287353,
DB2022_LFQ intensity R2,,0.5538464724946821,
GF2025_P6_Adh,,,
VOI2024_Veh1 di,,,
AS2011_Ratio H/L RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,,
VOI2024_Veh3 mono,,,
HS2024_5_I_T2,,,
NJH2025_Sub7_HIIT_Mid,,,
MV2014_Ratio H/L normalized B1___1 (30 min),,,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,,
RB2022_6_PostSprint,0.46845761504112365,0.5644458946378196,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,,
AS2011_Ratio H/L Inhi_1,,,
AS2011_Ratio H/L Normalized RNAi_1_2,,,
AH2018_TMTMS3_2_C,,0.5594173821007554,
SR2019_Hs578T_Biol_repl_4,,,
RB2022_8_PreStrength,0.4804986411461014,0.5588491285699138,
KS2014_Intensity C5,,0.5700633186936133,
RM2024_Intensity D0-1,,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,,
YP2020_Intensity P30_R1_mult_log2,,,
NJH2025_Sub2_HIIT_Pre,,,
RB2022_3_RecoveryEndurance,0.455696501229226,0.5484485372580483,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,,
GF2025_P9_Adh,,,
RB2022_3_PostStrength,0.4509102157333349,0.5878566337015282,0.7232253805223676
TM2022_S2.8h.A,,,
AS2011_Ratio H/L RNAi_1_1,,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,,
NJH2025_Sub2_MICT_Pre,,,
MV2014_Ratio L/M normalized A2___3 (10 min),,,
MV2014_Ratio H/M normalized A2___3 (2 min),,,
HS2024_4_B_T2,,,
SR2019_BT549_Biol_repl_1,,,
AH2018_LFQ_M_4_N,,0.5543758749924126,
NJH2024_Sub8_HIIT_Mid,,,
PG2020_Intensity 8h_B,,,
AH2018_LFQ_2_X,,0.5514148264987945,
PG2020_Intensity 2h_B,,,
AS2011_Ratio H/L Proteins RNAi_1,,,
RB2022_4_PostSprint,0.468019448481684,0.5412076218771332,
KS2014_Intensity E15_3,,0.5497274763336416,
GF2025_P3_Sph,,,
DB2022_LFQ intensity L2,,0.540520549323833,
MV2014_Ratio H/L normalized A1___1 (10 min),,,
AH2018_SILAC_1_C,,0.548002595553156,
NJH2024_Sub1_HIIT_Pre,,,
FSO2013_Ratio M/L normalized Rep2___2,,,
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,0.5423708783372024,0.6572263216715236
AS2011_Ratio H/L RNAi_2_3,,,
AH2018_SILAC_IT_1_N,,0.5515594061974419,
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,,
RB2022_4_PreEndurance,0.4548596144642974,0.5654359683626097,
JJ2018_Ratio M/L normalized pP1,,,
CR2017_Ratio Replicate 2.4,,0.5605536519628189,
ZQ2022_N1,,0.5466027869425015,
LY2019_P6-,,0.5500983941188369,
RM2024_Intensity D2-3,,,
UK2020_HCM_1,,0.5483175303373916,
JW2015_Intensity pre2,0.4433421323543474,0.5537548066622544,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,,
RM2024_Intensity D2-1,,,
NJH2025_Sub12_MICT_Post,,,
MV2014_Ratio H/M normalized B2___2 (5 min),,,
RN2012_L14,,0.5433920188528093,
AH2018_LFQ_3_N,,0.5376443572745161,
RKK2015_TNF-α/IKKb,,,
SFR2015_HL_log2_ratio_std_b,,,
UK2020_UA_1,0.4601268466494711,0.5486919797130677,
KBE2022_Log2_Ex_13_U,,0.5617999220687989,
AS2011_Ratio H/L Normalized Inhi_1,,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,,
RB2022_1_RecoverySprint,0.4639179997651885,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,,
JJ2018_Ratio H/L normalized pP3,,,
CK2022_7 40-1,,,
AS2011_Ratio H/L Inhi_1_3,,,
NJH2025_Sub10_HIIT_Mid,,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,,
JAW2011_Ratio H/L LS1b_1,,,
PG2020_Intensity 4h_B,,,
SR2019_BT549_Biol_repl_2,,,
RM2024_Intensity D4-2,,,
DB2022_LFQ intensity R2.2,,0.5578692763506562,
JJ2018_Ratio H/L normalized,,,
RB2022_5_PostEndurance,0.47132219290286975,0.5548952608944367,0.675824117995606
HS2024_5_PD_T2,,,
WZ2023_Su_025_20min,,0.5651031300395499,
RM2024_Intensity D2-2___1,,,
IMM2018_normalised rep. int. CDK5L-2,,,
LY2019_P8-,,0.5491912913311098,
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,,
FSO2013_Ratio H/L normalized Rep1,,,
NJH2024_Sub2_HIIT_Pre,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,,
CK2022_13 40-1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,,
RN2012_H02,,,
PG2020_Intensity 10h_D,,,
RB2022_8_PreEndurance,0.45728351378053333,0.5536759127704495,
HS2024_3_B_N2,,,
EJN2021_4_Ex_Ins,0.46434914320926,0.5725731410876255,
AS2011_Ratio H/L Normalized by Protein,,,
EJN2021_1_Ex_Ins,0.45408580695508505,0.5652542654979603,
EP2017_Pervanadate R#3 log2 ratio,,0.5708444947626808,
FSO2013_Ratio M/L normalized Rep1___3,,,
NJH2025_Sub4_HIIT_Mid,,,
RCJD2014_5min_2,,,
RB2022_6_PostStrength,,,
AH2018_SILAC_MR_3_C,,,
AH2018_LFQ_M_4_C,,,
NJH2024_Sub4_MICT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_1_1,,,
DL2023_12h-1,,0.5470995416505191,
MV2014_Ratio L/M normalized B2___1 (30 min),,,
DB2022_LFQ intensity L1.1,,0.5303192154848734,
NJH2025_Sub6_MICT_Pre,,,
NJH2025_Sub6_MICT_Post,,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,,
RN2012_H04,,,
CK2022_6 40-1,,,
DB2022_LFQ intensity R2.1,,0.5577836055659446,
KBE2022_Log2_Ex_42_U,,0.5564872084414144,
LY2019_P3-,,0.5522112417423465,
FR2021_Intensity.A,,,
EJN2021_3_Ex_Ins,0.44402284859057717,0.5601691682699622,
MV2014_Ratio M/L normalized A1___1 (2 min),,,
WZ2023_Pe_005_30min,,0.5595623605839793,
HS2024_8_PD_T3,,,
EJN2021_3_Ex_Basal,0.4507759145518355,0.5570751669167898,
AST2020_Control.1,,,
JW2015_Intensity cap1,0.4518141312072633,0.5595092448061455,
PG2020_Intensity CT_A,,,
FS2019_Ctr3,,,
WZ2023_Pu_025_20min,,0.5627090688155947,
NJH2025_Sub4_MICT_Post,,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,,
GF2025_P10_Adh,,,
RB2022_1_RecoveryStrength,0.4488107223431864,0.560669799731624,0.6728823391655404
SR2019_HCC1954_Biol_repl_4,,0.5552801832094975,
FR2021_Norm.Intensity.N,,,
HS2024_5_B_N1,,,
FSO2013_Ratio H/M normalized Rep3___3,,,
AH2018_TMTMS2_2_C,,0.5543729777900425,
RB2022_4_PreSprint,0.45900068301459673,0.5644508511568512,
DB2022_Intensity R2,,0.5451706225099037,
AH2018_TMTMS2_Pool,,0.560804878787527,
HS2024_8_I_N2,,,
RB2022_3_RecoveryStrength,0.4667044662106795,0.5592018354532438,0.5914143498532923
NJH2024_Sub6_HIIT_Mid,,,
AH2018_SILAC_M_1_C,,0.5491930366391201,
LY2019_P8+,,0.5441718235865728,
RB2022_2_RecoveryEndurance,0.45215972975500596,0.547873375400567,0.6007269839918775
JJ2018_Ratio H/M normalized pP2___1,,,
JAW2011_Ratio H/L HS_1,,,
RB2022_3_PostEndurance,0.46849699157322494,0.5625925967756423,0.6926208972104492
KS2014_Intensity pY_PV1,0.46787223770437414,,
JAW2011_Ratio H/L LS1b_2,,,
SR2019_MCF7_Biol_repl_2,,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,0.5647121553808842,0.6407901769664917
AS2011_Ratio H/L Normalized RNAi_1_1,,,
AH2018_LFQ_M_4_X,,0.5333500220119869,
NJH2024_Sub6_MICT_Pre,,,
JJ2018_Ratio M/L normalized pP1___2,,,
YP2020_Intensity C30_R2_mult_log2,,,
NJH2024_Sub9_HIIT_Pre,,,
AS2011_Ratio H/L Normalized Inhi_2_3,,,
RM2024_Intensity D0-1___3,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,,
KBE2022_Log2_Ex_28_U,,0.5538560816345234,
GRW2016_Ratio H/L normalized SILAC 1___1,,,
CF2017_FTE 17,,,
LY2019_P2-,,0.543109171038303,
AH2018_LFQ_IT_1_X,,0.5470486352554883,
JJ2018_Ratio H/L normalized pP3___1,,,
RB2022_8_RecoveryStrength,0.4617923354978824,0.5449083965319326,
WZ2023_Pe_005_20min,,0.5602206608443434,
AST2020_Control.2,,,
NJH2025_Sub6_MICT_Mid,,,
RCJD2014_10min_1,,,
FSO2013_Ratio H/L normalized Rep2___3,,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,,
HS2024_3_I_T1,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,,
CK2022_4 40-1,,,
SR2019_MCF10A_Biol_repl_4,,0.5109672526036891,
KS2014_Intensity pY_C5,0.45679777332871274,,
NJH2025_Sub4_MICT_Pre,,,
NJH2024_Sub9_MICT_Post,,,
CF2017_OSE 28,,,
HS2024_5_B_T2,,,
HS2024_6_I_T1,,,
HS2024_5_B_T3,,,
JJ2018_Ratio H/M normalized pP1___1,,,
KBE2022_Log2_Ex_36_U,,0.5617364987791545,
AH2018_TMTMS3_3_N,,0.5593222677897324,
SR2019_HCC1419_Biol_repl_2,,0.5351335643536199,
FR2021_Intensity.N,,,
AS2011_Ratio H/L Inhi_2_1,,,
AH2018_SILAC_MR_1_C,,,
NJH2024_Sub1_HIIT_Mid,,,
NJH2025_Sub8_HIIT_Mid,,,
EP2017_Mitotic R#3 log2 ratio,,0.536027552068279,
KBE2022_Log2_Ex_36_T,,0.5614693939352918,
NJH2025_Sub6_HIIT_Mid,,,
WZ2023_Pu_005_30min,,0.564839362078745,
KS2014_Intensity C2,,0.5746485211818164,
FSO2013_Ratio H/L normalized Rep1___2,,,
RM2024_Intensity D2-2,,,
KBE2022_Log2_Ex_42_T,,0.5548088069983815,
CK2022_9 200-1,,,
GRW2016_Ratio H/L normalized SILAC 2___1,,,
JJ2018_Ratio H/M normalized pP3___2,,,
DB2022_LFQ intensity R1.1,,,
CK2022_10 200-1,,,
NJH2024_Sub9_MICT_Mid,,,
JAW2011_Ratio H/L_2,,,
HS2024_7_I_N2,,,
RBK2021_1332T Late,,,
LY2019_P1-,,0.5387096289240065,
RKK2015_TNF-α/basal.1,,,
RKK2015_TNF-α/TNF-α+SC-514,,,
CR2017_Ratio Replicate 2.5,,0.543473020910154,
HS2024_3_I_T3,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,,
AS2011_Ratio H/L Normalized RNAi_1,,,
KS2014_Intensity E15_4,,0.5624231380560171,
ZQ2022_C3,,0.55254939239478,
EJN2021_3_Rest_Ins,0.45146843743637444,0.5505928590004521,
YP2020_Intensity P10_R2_mult_log2,,,
MV2014_Ratio H/L normalized A1___3 (10 min),,,
NJH2025_Sub1_MICT_Pre,,,
KBE2022_Log2_Ex_39_T,,0.5516005654726281,
FSO2013_Ratio H/M normalized Rep3___2,,,
RM2024_Intensity D6-2,,,
EP2017_Untreated R#1 log2 ratio,,0.54372400136846,
RKK2015_SC-514/basal,,,
RM2024_Intensity D6-1___3,,,
WZ2023_Pu_010_10min,,0.561632321700763,
NJH2025_Sub9_HIIT_Mid,,,
SR2019_SKBR3_Biol_repl_4,,0.5606793061275376,
HS2024_5_I_T3,,,
KS2014_Intensity N1,,0.5647748008419776,
NJH2024_Sub12_MICT_Post,,,
TM2022_S2.8h.C,,,
CR2017_Ratio Replicate 1,,0.5489694894724416,
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,,
JJ2018_Ratio H/M normalized pP3,,,
AH2018_SILAC_MR_2_C,,,
LATM2013_Log2 Ratio (Medium/Light) Forward,,0.5670256133181462,
PG2020_Intensity 2h_A,,,
NJH2024_Sub6_MICT_Mid,,,
NJH2025_Sub13_HIIT_Post,,,
AH2018_SILAC_MR_3_X,,,
JJ2018_Ratio H/M normalized___1,,,
RCJD2014_15min_2,,,
AS2011_Ratio H/L_2,,,
AS2011_Ratio H/L Normalized,,,
RN2012_H03,,0.55724562870892,
HS2024_5_B_N2,,,
HS2024_5_I_N1,,,
HS2024_6_I_N1,,,
AR2021_KD 48h,,,
FR2021_Intensity.B,,,
RB2022_3_PreEndurance,,0.546639907052268,0.6197174336227117
HS2024_5_I_T1,,,
NJH2024_Sub10_MICT_Pre,,,
SR2019_LM2_Biol_repl_2,,,
AST2020_anti-CD3,,,
SR2019_MDAMB231_Biol_repl_1,,,
RM2024_Intensity D2-3___3,,,
WZ2023_Pe_005_10min,,0.5627310844324395,
KBE2022_Log2_Ex_29_U,,0.555654906542678,
HS2024_7_B_T1,,,
AH2018_LFQ_M_2_X,,0.5539746248806857,
AH2018_LFQ_IT_4_N,,0.5431169561569213,
CK2022_15 200-1,,,
RM2024_Intensity D4-1___2,,,
JJ2018_Ratio H/M normalized,,,
JJ2018_Ratio M/L normalized pP3___1,,,
KBE2022_Log2_Ex_34_T,,0.5599838813149763,
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,,
LY2019_P2+,,0.5483917645465478,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,0.5714046781862171,
CK2022_2 200-1,,,
AS2011_Ratio H/L Protein RNAi_2,,,
MV2014_Ratio L/H normalized A3___1 (2 min),,,
WZ2023_Su_010_30min,,0.5649313944526667,
RN2012_H01,,,
KTGR2014_Ratio-Rapa 2 mins,,,
EJN2021_2_Rest_Basal,0.465664695979343,0.5717728892370595,
KS2014_Intensity pY_E5_3,,,
MM2018_Ratio H/L replicate 3,,,
EP2017_Pervanadate R#1 normalized log2 ratio,,0.5679798091832872,
HS2024_8_B_T3,,,
YA2020_Reporter_intensity_Cancer_No.3,,0.5577751312186263,
KBE2022_Log2_Ex_44_U,,0.5584329906393006,
WZ2023_Pe_010_20min,,0.5615624195665588,
KS2014_Intensity pY_C6,0.4601854562442366,,
AS2011_Ratio H/L Normalized_3,,,
RCJD2014_15min_mean,,,
RB2022_3_PreStrength,0.4559358532332088,,0.5966271298637679
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,,0.6543585329081267
RCJD2014_10min_mean,,,
KS2014_Intensity C1,,0.5734509473170102,
FSO2013_Ratio H/M normalized Rep3___1,,,
AH2018_SILAC_M_3_C,,0.5425252823523128,
RKK2015_TNF-α+IKKb/TNF-α,,,
RM2024_Intensity D0-3___2,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,,
AH2018_SILAC_M_2_C,,0.5164987711399032,
AH2018_SILAC_M_2_X,,0.519250134866409,
KTGR2014_Ratio-Rapa 15 mins,,,
RM2024_Intensity D4-2___1,,,
KBE2022_Log2_Ex_15_T,,0.5611257877026471,
VOI2024_0.1uM 24 h_1 di,,,
WZ2023_Su_010_10min,,0.5664841127501975,
PG2020_Intensity 6h_C,,,
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,,
JJ2018_Ratio M/L normalized pP1___1,,,
AH2018_LFQ_M_3_N,,0.5432038554824706,
VOI2024_0.1uM 24 h_2 mono,,,
AH2018_TMTMS2_3_C,,0.5538130795010291,
CK2022_15 16-1,,,
CK2022_3 16-1,,,
LY2019_P4-,,0.5593337319673206,
FSO2013_Ratio H/L normalized Rep3___2,,,
KS2014_Intensity pY_PV2,0.47463378152419605,,
HS2024_3_I_N2,,,
GF2025_P8_Adh,,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,,
GF2025_P5_Sph,,,
CK2022_10 16-1,,,
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,,
VOI2024_0.1uM 2 h_2 di,,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,0.5528464229522912,0.6467585205578436
NJH2024_Sub2_HIIT_Mid,,,
AMK2021_45I_p3,,,
NJH2024_Sub13_HIIT_Mid,,,
DB2022_LFQ intensity R1.2,,0.5467196509250174,
DB2022_Intensity R1,,0.5460343997318633,
NJH2024_Sub12_MICT_Mid,,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,,
UK2020_HCM_4,,0.5503975455103957,
SAS2015_AZD/DMSO_Exp2,,,
IMM2018_normalised rep. int. CDK5L-1,,,
DB2022_LFQ intensity L2.2,,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,,
EP2017_Mitotic R#1 log2 ratio,,0.5446985102847253,
EJN2021_2_Ex_Basal,0.46516488720924987,0.5687407245116525,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,,
KTGR2014_Ratio-Rapa 30 mins,,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,,
CF2017_FTE 16,,,
AR2021_L41 10 μM,,,
CF2017_EOC 2,,,
RB2022_6_PostEndurance,0.47235977724069206,0.5731454151049793,
AH2018_SILAC_1_N,,0.547369078616351,
NJH2024_Sub10_HIIT_Pre,,,
AS2011_Ratio H/L Inhi_1_2,,,
UK2020_HCM_6,0.45924853512526603,0.550708896215527,
RB2022_7_PreSprint,0.4590557506537734,0.5405943896724582,0.6136562803041775
NJH2024_Sub2_MICT_Pre,,,
HS2024_3_PD_T2,,,
CK2022_6 16-1,,,
ZX2022_CB treated Replicate 1,,0.558845167219565,
BS2014_Log2(Ratio H/L normalized Rep_3),,,
TM2022_mock.12h.C,,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,,
HH2022_Reporter intensity 0,0.45703185211908604,,
RM2024_Intensity D2-2___2,,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,,
RB2022_1_PreStrength,0.46093423251255805,0.553752356893276,0.6917193318983709
JJ2018_Ratio H/M normalized pP2___2,,,
AH2018_TMTMS2_2_X,,0.5531590931735179,
AR2021_L41 1 μM,,,
JJ2018_Ratio H/M normalized pP1___2,,,
AH2018_TMTMS2_1_N,,0.555153308217636,
NJH2025_Sub10_MICT_Pre,,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,,
ZX2022_Control Replicate 3,,0.5570403012682495,
KS2014_Intensity C4,,0.5462721351195076,
AS2011_Ratio H/L Inhi_2,,,
KBE2022_Log2_Ex_18_T,,0.5564930115490889,
NJH2025_Sub9_MICT_Pre,,,
RCJD2014_20min_1,,,
MV2014_Ratio H/M normalized B2___1 (5 min),,,
FSO2013_Ratio M/L normalized Rep2___3,,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,,
SR2019_MCF10A_Biol_repl_3,,,
HS2024_7_B_T2,,,
SAS2015_PLX/DMSO_Exp3,,,
AMK2021_Ctrl_p5,,,
NJH2025_Sub2_HIIT_Mid,,,
AH2018_LFQ_M_3_C,,0.5559895180269054,
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,,
YA2020_Reporter_intensity_Cancer_No.2,,0.5620549015739761,
FSO2013_Ratio H/M normalized Rep2___3,,,
RB2022_8_PreSprint,0.460945949780914,0.5538648919803822,
AH2018_SILAC_IT_3_C,,0.5525433194903496,
WZ2023_Pu_025_10min,,0.5634279580324164,
RM2024_Intensity D2-2___3,,,
AS2011_Ratio H/L_1,,,
RCJD2014_10min_3,,,
FSO2013_Ratio M/L normalized Rep3___1,,,
SR2019_JIMT1_Biol_repl_4,,0.5535110381228387,
YP2020_Intensity C10_R2_mult_log2,,,
ZCP2016_Ratio H/L Rep 2,,,
CF2017_EOC 4,,,
JJ2018_Ratio H/L normalized pP1___1,,,
WZ2023_Pe_010_30min,,0.5617557539921179,
MV2014_Ratio L/M normalized B2___3 (30 min),,,
AH2018_LFQ_IT_3_N,,0.5278494832868675,
KS2014_Intensity C6,,0.5385841613143563,
ZQ2022_N3,,0.5440529020259742,
HW2015_Ratio H/L normalized Exp1,,,
CK2022_12 40-1,,,
NJH2024_Sub7_MICT_Pre,,,
ZX2022_Control Replicate 1,,0.5576230812876969,
JJ2018_Ratio H/M normalized pP1,,,
CK2022_16 40-1,,,
AH2018_SILAC_IT_2_C,,0.552537126646151,
CK2022_5 40-1,,,
AH2018_LFQ_3_X,,0.5459418325438117,
UK2020_UA_3,0.4604759846173322,0.5513916008229718,
LY2019_P7-,,0.5607381928396299,
GF2025_P5_Adh,,,
RB2022_1_PostStrength,0.4477989247321096,0.5620278984844239,0.6517551084629004
JAW2011_Ratio H/L LS1b,,,
FSO2013_Ratio H/L normalized Rep3___1,,,
SR2019_HCC1954_Biol_repl_3,,0.5559394433944278,
CR2017_Ratio Replicate 2.2,,0.5273521039678997,
VOI2024_0.1uM 2 h_1 mono,,,
MV2014_Ratio L/M normalized A2___1 (10 min),,,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,,
CK2022_11 16-1,,,
ZQ2022_C1,,0.5507320953801045,
CR2017_Ratio Replicate 2.1,,0.5256585792110392,
PG2020_Intensity CT_B,,,
JJ2018_Ratio M/L normalized___2,,,
AH2018_SILAC_MR_1_N,,,
KS2014_Intensity pY_E5_1,,,
JW2021_Before_3,,0.5465364062961773,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,,0.6619800675701825
MV2014_Ratio M/H normalized B3___3 (30 min),,,
FS2019_db/db1,,,
NJH2025_Sub9_HIIT_Pre,,,
JAW2011_Ratio H/L_1,,,
RCJD2014_20min_3,,,
AH2018_LFQ_3_C,,0.5538125731421086,
JJ2018_Ratio M/L normalized pP3___2,,,
AMK2021_45I_p1,,,
NJH2025_Sub8_HIIT_Post,,,
AH2018_LFQ_M_3_X,,0.5342499358717695,
YA2020_Reporter_intensity_Cancer_No.4,,0.5626395140957956,
KS2014_Intensity pY_E5_2,,,
FSO2013_Ratio H/L normalized Rep1___3,,,
GF2025_P4_Sph,,,
RB2022_2_PreEndurance,,,0.6182466033998382
JW2021_Before_1,,0.5429610052279102,
KBE2022_Log2_Ex_25_T,,0.5546940188930756,
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,,
MV2014_Ratio L/M normalized A2___2 (10 min),,,
JJ2018_Ratio M/L normalized___1,,,
FR2021_Intensity.H,,,
CK2022_14 16-1,,,
AST2020_anti-CD3+PDL2,,,
MV2014_Ratio M/L normalized B1___1 (5 min),,,
KBE2022_Log2_Ex_19_T,,0.5558791707414097,
KS2014_Intensity pY_N1,,,
RB2022_1_RecoveryEndurance,0.46138349976755944,0.5701353280253127,0.6423351028781854
FSO2013_Ratio H/M normalized Rep1___2,,,
HS2024_8_I_T1,,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,,0.6585988531403917
EP2017_Mitotic R#2 log2 ratio,,0.5426838021858993,
AH2018_TMTMS2_1_X,,0.5544906573965218,
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,,
ZCP2016_Ratio H/L Rep 3,,,
AS2011_Ratio H/L Normalized RNAi_1_3,,,
SR2019_MCF10A_Biol_repl_1,,,
NJH2025_Sub8_MICT_Mid,,,
EJN2021_5_Ex_Ins,0.4578542164936837,0.5690064718877899,
HS2024_6_I_N2,,,
HH2022_Reporter intensity 4,,,
RBK2021_1326T Late,,,
TM2022_mock.12h.B,,,
NJH2024_Sub12_MICT_Pre,,,
RCJD2014_15min_3,,,
MV2014_Ratio L/H normalized B3___2 (5 min),,,
LG2023_Control-3_intensity,,,
JJ2018_Ratio H/L normalized pP3___2,,,
CF2017_FTE 15,,,
HS2024_4_I_T3,,,
AH2018_SILAC_1_X,,0.5470835435715629,
PG2020_Intensity 10h_B,,,
AH2018_TMTMS3_1_X,,0.5592018577998066,
CF2017_FTE 14,,,
NJH2024_Sub13_HIIT_Post,,,
RM2024_Intensity D6-3___3,,,
NJH2025_Sub7_HIIT_Pre,,,
RBK2021_1259T Early,,,
RKK2015_IKK+TNF-α/IKKb,,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,,
PG2020_Intensity 6h_A,,,
SR2019_HCC1419_Biol_repl_3,,0.564189808281783,
KBE2022_Log2_Ex_14_T,,0.5537562931447494,
EP2017_Untreated R#2 normalized log2 ratio,,0.5550787489963985,
RM2024_Intensity D0-2___1,,,
DB2022_Intensity L1,,0.5312266303243931,
LY2019_P5+,,0.550828291701971,
HS2024_5_I_N2,,,
SAS2015_PLX/AZD_Exp3,,,
EP2017_Pervanadate R#2 log2 ratio,,0.5712514377102997,
AS2011_Ratio H/L Normalized RNAi_2_1,,,
